TIAA CREF Investment Management’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-5,473
Closed -$205K 3220
2016
Q1
$205K Hold
5,473
﹤0.01% 2973
2015
Q4
$374K Hold
5,473
﹤0.01% 2972
2015
Q3
$316K Buy
5,473
+305
+6% +$27K ﹤0.01% 2991
2015
Q2
$408K Buy
+5,168
New +$348K ﹤0.01% 3020
2014
Q2
Sell
-5,559
Closed -$436K 3215
2014
Q1
$436K Hold
5,559
﹤0.01% 2981
2013
Q4
$339K Buy
5,559
+335
+6% +$19.5K ﹤0.01% 3035
2013
Q3
$343K Sell
5,224
-918
-15% -$74.2K ﹤0.01% 3014
2013
Q2
$564K Buy
+6,142
New +$508K ﹤0.01% 2896

Other funds holding FCSC

TIAA CREF Investment Management's FCSC Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 5,473 shares — an estimated $205K sold.

TIAA CREF Investment Management first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $564K in Q2 2013. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 5,473 Fibrocell Science Inc. shares in Q2 2016, an estimated $205K.
  • TIAA CREF Investment Management first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
  • TIAA CREF Investment Management's Fibrocell Science Inc. position peaked at $564K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.